NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered Retatrutide from Dankang BioHealth? Mail in a sample (US only) and let us test it for free.

Test my supply
+10 more ↓
76%
Finnrick rating
#218 of 378 Retatrutide vendors
26 of 34 classifiable tests passed
customers 4.6★ (36)
methodology · Purity focus
Finnrick analysis · Retatrutide

Dankang BioHealth Retatrutide fell from an early clean streak into repeated 0 mg identity failures and fill volatility. Recent issues include a latest identity failure, a 94.9% purity miss, and a -52% fill result.

methodology →
vendor intelligence report
Vendor Intelligence Report: Dankang BioHealth

Corporate-registry checks and a same-template storefront cluster complicate Dankang’s factory narrative. The full report traces anti-fraud popups, stripped WhatsApp fields, Reddit dispute-cancellation allegations and a YanSen page praising Dankang by name.

27 pages5 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.05
87%
7
2
Retatrutideselected
$0.80
76%
34
3
Tirzepatide
$0.49
70%
10
4
SS-31
$0.75
63%
3
5
BPC-157
$0.67
51%
7
6
Tesamorelin
$2.14
50%
9
7
KLOW
$0.33
50%
3
8
TB-500
$1.52
36%
6
9
CJC-1295
$4.00
30%
3
10
NAD+
$0.01
29%
6
11
MOTS-c
$0.78
26%
6
12
5-Amino-1MQ
$0.67
-
0
13
Epithalon
$0.33
-
0
14
Glutathione
$0.01
-
0
15
Ipamorelin
$1.24
-
0
16
KPV
$0.63
-
0
17
Semax
$0.59
-
0
18
VIP
$1.82
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%1 Jan 2026: 77%7 Jan 2026: 78%15 Jan 2026: 79%19 Jan 2026: 81%22 Jan 2026: 82%11 Feb 2026: 84%13 Feb 2026: 85%18 Feb 2026: 86%20 Feb 2026: 87%22 Feb 2026: 88%1 Mar 2026: 84%2 Mar 2026: 80%3 Mar 2026: 77%4 Mar 2026: 78%6 Mar 2026: 79%6 Mar 2026: 80%21 Apr 2026: 81%23 Apr 2026: 82%26 Apr 2026: 82%26 Apr 2026: 79%28 Apr 2026: 80%30 Apr 2026: 81%6 May 2026: 82%8 May 2026: 79%8 May 2026: 80%15 May 2026: 77%25 May 2026: 78%27 May 2026: 75%1 Jun 2026: 76%17 Jun 2026: 74%24 Jun 2026: 74%20 Jul 2026: 75%23 Sep 2026: 76%23 Sep 2026: 77%29 Sep 2026: current 76%77%81%76%Jan 26Sep 26
Showing Retatrutide tests only
Free peptide testing

Ordered Retatrutide from Dankang BioHealth? Mail in a sample (US only) and let us test it for free.

Test my supply
Dankang BioHealth Retatrutide test history
COA-backed lab tests
1-10 of 34

About Dankang BioHealth test results from Finnrick

Dankang BioHealth is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 11 peptides and 94 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Dankang BioHealth peptides in this dataset are BPC-157 (7 tests), CJC-1295 (3 tests) and GHK-Cu (7 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 94 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered Retatrutide from Dankang BioHealth? Mail in a sample (US only) and let us test it for free.

Test my supply